Mesenchymal stromal cell therapy reduces lung inflammation and vascular remodeling and improves hemodynamics in experimental pulmonary arterial hypertension

by Lucas de Mendonça, Nathane S. Felix, Natália G. Blanco, Jaqueline S. Da Silva, Tatiana P. Ferreira, Soraia C. Abreu, Fernanda F. Cruz, Nazareth Rocha, Patrícia M. Silva, Vanessa Martins, Vera L. Capelozzi, Gizele Zapata-Sudo, Patricia R. M. Rocco, Pedro L. Silva
Published 2017-10-01